Folgen
Saskia S. Rudat
Saskia S. Rudat
Scientific Project Manager and Postdoctoral Fellow, Lengerke Lab, University Hospital Tübingen
Bestätigte E-Mail-Adresse bei med.uni-tuebingen.de - Startseite
Titel
Zitiert von
Zitiert von
Jahr
RET-mediated autophagy suppression as targetable co-dependence in acute myeloid leukemia
S Rudat, A Pfaus, YY Cheng, J Holtmann, JM Ellegast, C Buehler, ...
Leukemia 32 (10), 2189-2202, 2018
632018
Association of the POT1 germline missense variant p. I78T with familial melanoma
K Wong, CD Robles-Espinoza, D Rodriguez, SS Rudat, S Puig, M Potrony, ...
JAMA dermatology 155 (5), 604-609, 2019
312019
Cut-like homeobox 1 (CUX1) tumor suppressor gene haploinsufficiency induces apoptosis evasion to sustain myeloid leukemia
E Supper, S Rudat, V Iyer, A Droop, K Wong, JF Spinella, P Thomas, ...
Nature Communications 12 (1), 2482, 2021
182021
The RET receptor tyrosine kinase promotes acute myeloid leukemia through protection of FLT3-ITD mutants from autophagic degradation
S Rudat, A Pfaus, C Bühler, S Rabe, L Bullinger, S Gröschel, SM Sykes, ...
Blood 128 (22), 2849, 2016
42016
Laminin Receptor Characterization in Acute Myeloid Leukemia: Integrin α7β1 Defines non-Leukemic Stem Cells with Migratory Potential
E Goersch, M Arnone, M Klimiankou, J Weller, S Rudat, G Klein, ...
bioRxiv, 2024.03. 29.587290, 2024
2024
P462: RECIPIENT SEX AND DONOR RISK GROUP INFLUENCE LEUKEMIA KINETICS IN NSG MICE
M Arnone, A Stanger, P Hanns, J Kuebler, E Goersch, S Rudat, ...
HemaSphere 7 (S3), e69200f6, 2023
2023
The Role of Mannose Receptor C-Type 2 (MRC2) in Leukemic Stem Cell Maintenance in AML
M Arnone, E Görsch, S Pöschel, A Stanger, S Rudat, C Lengerke
Blood 140 (Supplement 1), 8706-8706, 2022
2022
P384: THE ROLE OF THE MANNOSE RECEPTOR C-TYPE 2 (MRC2) IN LEUKEMIC STEM CELL MAINTENANCE IN AML
M Arnone, E Görsch, S Pöschel, P Godavarthy, A Stanger, S Rudat, ...
HemaSphere 6, 284-285, 2022
2022
S895 POT1 MUTATIONS DRIVE GENOMIC INSTABILITY AND CONFER SYNTHETIC LETHALITY WITH G-QUADRUPLEX STABILIZING AGENTS IN CHRONIC LYMPHOCYTIC LEUKEMIA
S Rudat, G Guilbaud, B Fu, A Silva, M Rashid, J Baxter, F Yang, J Sale, ...
HemaSphere 3 (S1), 403, 2019
2019
The RET Receptor Tyrosine Kinase Promotes AML Through Protection of Mutant FLT3 from Autophagic Degradation
SS Rudat
Ruperto-Carola University of Heidelberg, 2017
2017
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–10